Edmonton

Capital Power to highlight decarbonization focus at virtual Investor Day

Retrieved on: 
Monday, November 22, 2021

EDMONTON, Alberta, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Capital Power Corporation (TSX: CPX) will host its 13th annual Investor Day event virtually on December 2, 2021.

Key Points: 
  • EDMONTON, Alberta, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Capital Power Corporation (TSX: CPX) will host its 13th annual Investor Day event virtually on December 2, 2021.
  • A live and archived video webcast of the event will be available from Capital Powers website at: capitalpower.com
    Capital Power is a growth-oriented North American wholesale power producer with a strategic focus on sustainable energy headquartered in Edmonton, Alberta.
  • We have also made significant investments in carbon capture and utilization to reduce carbon impacts and are committed to be off coal in 2023.
  • Capital Power owns over 6,400 MW of power generation capacity at 26 facilities across North America.

Alberta Government TIER Funding to Establish Hydrogen Testing Facility

Retrieved on: 
Thursday, November 18, 2021

EDMONTON, Alberta, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Hydrogen is recognized as a key component in transitioning to a lower carbon future.

Key Points: 
  • EDMONTON, Alberta, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Hydrogen is recognized as a key component in transitioning to a lower carbon future.
  • The Government of Alberta has announced a $1,375,000 investment delivered through Alberta Innovates TIER Economic Recovery Program to expand C-FER Technologies ability to conduct full-scale tests in hydrogen-rich environments.
  • This funding will help advance commercial implementation of well and pipeline technologies for the hydrogen economy.
  • Combined with industry support, the funding of this project will complete the construction of an automated testing system designed to investigate the impact of hydrogen on pipelines.

LANAI Outdoors Calls for New Distributors After Launching Revolutionary Premium Decking Product in the US

Retrieved on: 
Thursday, November 18, 2021

Their truly innovative LANAI Premium Plank Decking replicates the beauty of genuine hardwood with the durability of high-end PVC, making it ideal for any North American climate.

Key Points: 
  • Their truly innovative LANAI Premium Plank Decking replicates the beauty of genuine hardwood with the durability of high-end PVC, making it ideal for any North American climate.
  • "The U.S. decking market is ready for something better, and LANAI Premium Plank Decking is the answer," says LANAI President, Dustin Wilson. "
  • LANAI is the first and only decking product that is shipped on stackable 48" x 48" pallets.
  • LANAI Outdoors was established in Edmonton, Alberta, Canada, in 2020, with a goal of filling the gap between beauty and durability in the decking industry.

Ceapro Inc. Reports 2021 Third Quarter and Nine-Month Financial Results and Operational Highlights

Retrieved on: 
Wednesday, November 17, 2021

EDMONTON, Alberta, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced financial results and operational highlights for the third quarter and the first nine months ended September 30, 2021.

Key Points: 
  • Pursued the development of new PGX-dried chemical complexes for potential applications under various forms like pills, capsules, fast dissolving strips and face masks.
  • Resumed bioavailability studies with University of Alberta for new chemical complexes yeast beta glucan-CoQ10, alginate-CoQ10 and newly formed alginate yeast beta glucan-CoQ10.
  • Achieved record levels with production of over 70 MT of finished products during the last quarter reliably providing our customers essential high quality products.
  • Increased net profit for the third quarter of 2021 comes from improved margin of 65.2% as compared to 47.8% in 2020.

Nabati Foods’ Nabati Plant Eggz™ Now Available in Quality Foods Throughout B.C.

Retrieved on: 
Wednesday, November 17, 2021

VANCOUVER, British Columbia, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Nabati Foods Global Inc. ( CSE: MEAL )( FSE:7UW ) (Nabati Foods or the Company), a plant-based food technology company offering whole, natural, plant-based foods for health-conscious consumers, is announcing that Nabati Plant Eggz are now available in all Quality Foods locations across British Columbia.

Key Points: 
  • VANCOUVER, British Columbia, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Nabati Foods Global Inc. ( CSE: MEAL )( FSE:7UW ) (Nabati Foods or the Company), a plant-based food technology company offering whole, natural, plant-based foods for health-conscious consumers, is announcing that Nabati Plant Eggz are now available in all Quality Foods locations across British Columbia.
  • We are pleased to be bringing our Nabati Plant Eggz to Quality Foods, a popular grocery store located on Vancouver Island and throughout coastal B.C., said Nabati Foods CEO Ahmad Yehya.
  • Nabati Foods wants to lead the evolution of food and our Nabati Plant Eggz are the latest example of that commitment, Yehya said.
  • Subscribe to updates about Nabati Foods here: https://invest.nabatifoods.com/
    About Nabati Foods Global Inc.
    Nabati Foods Global Inc. is the owner of Nabati Foods Inc. (Nabati Foods), a family-founded food technology company offering whole, natural, plant-based, gluten, and soy-free foods for health-conscious consumers.

Ceapro Inc. Reports Preliminary Results from Clinical Trial Evaluating Oat Beta Glucan in Patients with High Cholesterol Levels

Retrieved on: 
Wednesday, November 17, 2021

This clinical trial assessed the safety and efficacy of three dosages of oat beta glucan administered as 500 mg pills (1.5 g, 3 g and 6 g per day) compared to placebo.

Key Points: 
  • This clinical trial assessed the safety and efficacy of three dosages of oat beta glucan administered as 500 mg pills (1.5 g, 3 g and 6 g per day) compared to placebo.
  • A total of 263 patients (169 females and 94 males) were enrolled in the study.
  • The effect of oat beta glucan on the study primary endpoint of change in low-density lipoprotein cholesterol (LDL-C) was not statistically significant compared to placebo.
  • They are in accordance with recent data by Cicero et al.1 on another beta glucan nutraceutical formulation and reinforce the hypothesis that oat beta glucan may offer appreciable health benefits, as indicated in Health Canadas oat beta glucan approved monograph.

Carbon Fibre Grand Challenge Selects Successful Phase II Projects

Retrieved on: 
Tuesday, November 16, 2021

EDMONTON, Alberta, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Alberta Innovates and the Clean Resource Innovation Network (CRIN) have selected 12 projects to participate in Phase II of the Carbon Fibre Grand Challenge (CFGC) .

Key Points: 
  • EDMONTON, Alberta, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Alberta Innovates and the Clean Resource Innovation Network (CRIN) have selected 12 projects to participate in Phase II of the Carbon Fibre Grand Challenge (CFGC) .
  • Phase II of the Carbon Fibre challenge moves us closer to realizing the potential of Bitumen Beyond Combustion.
  • We are proud to lay the foundation for a stronger, greener, and more sustainable economy by investing in initiatives like CRINs Carbon Fibre Grand Challenge.
  • Carbon Fibre Grand Challenge Phase II Successful Applicants:

Stantec-Atkins-Dewberry team selected to support national flood mapping and risk mitigation for FEMA

Retrieved on: 
Tuesday, November 16, 2021

Projects under this architecture and engineering contract will include regional flood hazard modeling, floodplain mapping, and flood management services with the mission of increasing risk awareness and inspiring communities to take mitigative actions to reduce the risk to life and property.

Key Points: 
  • Projects under this architecture and engineering contract will include regional flood hazard modeling, floodplain mapping, and flood management services with the mission of increasing risk awareness and inspiring communities to take mitigative actions to reduce the risk to life and property.
  • The Risk MAP program supports communities by providing credible, qualityflood data,building partnerships, and informing long-term hazard mitigation planning to build resilience.
  • Risk MAPs Flood Risk Products provide information that enhance the development of hazard mitigation and risk-based mitigation strategies.
  • For more than 40 years, Stantec has supported FEMAs efforts to analyze and mitigate flood risk nationwide, providing engineering and mapping services to support the National Flood Insurance Program.

Inventures Announces 2021 Startup Pitch Winners

Retrieved on: 
Monday, November 15, 2021

"Entrepreneurs like those who were successful in our Startup Pitch Competition are showing us what the future can look like.

Key Points: 
  • "Entrepreneurs like those who were successful in our Startup Pitch Competition are showing us what the future can look like.
  • Were looking forward to returning to the live pitch format at Inventures 2022 next June in Calgary, with even more inspiring ideas.
  • Launched in 2018, Inventures is gaining global interest as the place to discover new technologies, talent, capital, customers and markets.
  • For more information about Inventures and the Startup Pitch Competition, please contact:

Ceapro Inc. Provides Update on Development of an Inhalable Therapeutic Using Yeast Beta Glucan Processed with Pressurized Gas eXpanded Technology (PGX-YBG)

Retrieved on: 
Thursday, November 11, 2021

EDMONTON, Alberta, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today provided an update on its ongoing collaboration with McMaster University to develop an inhalable therapeutic for COVID-19 which could also be used to treat post-COVID-19 conditions.

Key Points: 
  • While yeast beta glucan appeared to be a promising compound, researchers thought that the ideal formulation to treat fibrotic lung disorders would be to develop an inhalable complex produced by loading a drug onto PGX-processed yeast beta glucan (PGX-YBG).
  • The team has successfully demonstrated that Ceapros PGX technology can produce low density, highly porous, and purified YBG microparticles with a small and uniform size distribution.
  • At the heart of this project is fibrosis: the unregulated and excessive production of scar tissue in organs.
  • The Company has a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering.